Culture

Why do elephants and tigers still roam in India? Study offers clues

Tropical Asia and Africa are the only regions on Earth that retain diverse populations of large, land-dwelling mammals, such as elephants, rhinos, and big cats. A new study co-authored by Yale researcher Advait M. Jukar suggests that the persistence of mammalian megafauna in the Indian Subcontinent is related to the great beasts' long coexistence there with homo sapiens and other human ancestors.

The study, published in the journal Palaeogeography, Palaeoclimatology, Palaeoecology -- and based on a novel dataset drawn from 51 fossil sites in present-day India -- documents a low-magnitude extinction that began about 30,000 years ago. That was about 30,000 years after modern humans arrived in the Indian Subcontinent.

The analysis provides the first direct and independent test of the "co-evolution hypothesis," a commonly held theory that the magnitude of an extinction correlates with the amount of time that large mammals coexist with humans and their hominin ancestors, the researchers said.

"During the past 100,000 years, people have been implicated in the extinction of large, land-dwelling mammals all over the world, but Indian megafauna proved more resilient and, as in Africa, have co-existed with humans for much longer periods than in other regions," said Jukar, a Gaylord Donnelly Postdoctoral Associate at the Yale Institute for Biospheric Studies and the study's lead author. "Our work supports the idea that some large species co-evolved with human ancestors, adapting to their presence and developing behaviors that helped them cope with how they altered the habitat."

Jukar co-authored the study with S. Kathleen Lyons and Peter J. Wagner of the University of Nebraska-Lincoln, and Mark D. Uhen of George Mason University.

Not all large mammals on the Indian Subcontinent survived, of course. The researchers document the extinctions of Palaeoloxodon namadicus and Stegodon namadicus, two species of elephant; Hexaprotodon sp., a hippopotamus; and Equus namadicus, a zebra-like horse. They also show the extirpation, or local extinction, of ostriches, which survive elsewhere, and the "pseudo-extinction" of the Indian aurochs -- the wild ancestor of the domestic zebu cattle that thrive in India today. The four extinctions represent about 4% of mainland India's mammalian fauna and 20% of its mammalian megafauna, animals weighing more than 50 kilograms, or 110 pounds. Human activity combined with the species' limited ranges and slow reproduction rates contributed to these extinctions, Jukar said

The extinction rate in India over the past 50,000 years is comparable to that of eastern and southern Africa, but 2.5 times smaller than in South America and 4 times smaller than in North America, Europe, Madagascar, and Australia, according to the study. The researchers noted that India's extinction pattern is strikingly similar to that of Africa, where humans first evolved, lending support to the co-evolution hypothesis. (The first hominins-- a group that includes modern humans and all our immediate ancestors -- arrived in India about 1.7 to 1.5 million years ago.) The researchers conclude that, as in Africa, land-dwelling megafauna provided remarkably resilient to human pressures. They found that the presence of other hominins had little to no impact on the Indian Subcontinent's animal life and posit that early humans may have preferred to hunt smaller prey, such as primates or rodents, to megafauna.

The researchers also analyzed the role of contemporary climate change trends -- including temperature fluctuations and varying monsoon intensity -- on the extinction pattern. While changes in climate may have elevated the extinction risk for species that were dependent on annual water sources, such as Hexaprotodon sp., the researchers found that climate change alone does not explain the low-magnitude but strongly size-biased extinction that they documented. The researchers noted that all of the extinct species they identified had survived periods of drought.

The researchers also note that Asian elephants, tigers, and other large mammals in India had extensive ranges extending from Turkey to Southeast Asia, which improved their chances of survival. The extinct species' ranges, however, were limited to the Indian Subcontinent, the researchers explain. They note that some species, including the Asian elephant, are known to inhabit refugia -- areas that offer protection during drought and other periods when conditions become unfavorable.

The fact that India's large mammals have proven resilient to the presence of humans is no excuse to become lax about conservation, Jukar cautioned.

"Today's mammals are facing many of the same pressures that these extinct mammals faced, but they are confined to smaller and smaller ranges," he said. "Climate change and the human activities that caused the extinctions we've documented are now accelerating at unprecedented rates. If we ignore these factors, we will lose the elephants, rhinos, and tigers that have survived."

Credit: 
Yale University

Researchers identify critical molecules that coronaviruses hijack to infect human cells

image: Melanie Ott co-led a study with researchers from Gladstone, the Chan Zuckerberg Biohub, UC San Francisco, and Synthego Corporation that points toward ways to treat not only COVID-19, but future coronaviruses that might emerge.

Image: 
Photo: Gladstone Institutes

SAN FRANCISCO, CA--December 8, 2020--When a coronavirus--including SARS-CoV-2, which causes COVID-19--infects someone, it hijacks the person's cells, co-opting their molecular machinery for its own survival and spread. Researchers at Gladstone Institutes and the Chan Zuckerberg Biohub, in collaboration with scientists at UC San Francisco (UCSF) and Synthego Corporation, have identified critical molecular processes in human cells that coronaviruses use to survive.

They report, in a study published in the journal Cell, that targeting these processes with drugs may treat not only COVID-19 infections, but other existing and future coronaviruses.

"What is unique about our study is that we didn't just look at SARS-CoV-2, but other coronaviruses at the same time," says one of the leaders of the study, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology. "This gives us a good idea of drug targets that could broadly suppress many coronaviruses."

A large family of viruses, coronaviruses include common cold viruses as well as more severe viruses. The SARS-CoV virus that caused a deadly SARS epidemic in 2002 was a coronavirus, as is the MERS virus, which has caused outbreaks in the Middle East.

"There have now been multiple coronavirus outbreaks, so it's clear this virus family has high pandemic potential," says Andreas Puschnik, PhD, a principal investigator at the Chan Zuckerberg Biohub and the other leader of the study. "COVID-19 is not the last coronavirus infection we'll be dealing with."

Comparing and Contrasting Coronaviruses

Like all viruses, coronaviruses can only grow inside host cells; they rely on the host cell's molecules to multiply. Because of this, the team of researchers want to target human molecules that the viruses use to survive, rather than components of viruses themselves.

In the new study, they infected human cells with either SARS-CoV-2 or two other coronaviruses that cause common colds--and all three viruses killed the cells. Next, the team of researchers mutated the cells using CRISPR-Cas9 gene-editing technology and studied which mutations made the cells less vulnerable to the coronaviruses.

"We reasoned that the few cells that could survive these infections presumably had mutations in host molecules that the viruses use to infect them or to multiply," explains Puschnik.

Some results were not surprising. For instance, the human ACE2 receptor is known to be required by SARS-CoV-2 to enter human cells. So, cells with a mutation in the ACE2 gene were no longer infected or killed by SARS-CoV2.

But other findings were less expected. The researchers found that certain genetic mutations prevented all three coronaviruses from successfully infecting and killing the cells. These were mutations in genes known to control the balance of two types of lipid molecules in human cells, namely cholesterol and phosphatidylinositol phosphate (PIP).

Cholesterol is needed for some viruses to enter cells, but it hadn't been studied in the context of coronaviruses when this study started. Similarly, PIP is known to play a role in forming the small vesicles that viruses often use to travel into and around cells, but it had not been directly linked to SARS-CoV-2 before.

A Pathway toward Therapeutics

To verify the importance of the cholesterol and PIP genes for coronavirus infection, the researchers engineered human cells that lack these genes completely and infected them with the virus. Cells lacking the genes were protected from infection by all three coronaviruses. Similarly, when the team used existing compounds to disrupt the balance of PIP or cholesterol, the cells were less susceptible to infection by any of the viruses.

These results suggest that targeting cholesterol or PIP could be a promising strategy to combat multiple coronaviruses.

"For viruses, the traditional view has been that we design drugs against unique viral targets, and that means it takes time to develop a drug each time there's a new virus," says Ott, who is also a professor in the Department of Medicine at UCSF. "If we could develop a few broader antiviral drugs that target host cells' molecules, that would go a long way toward making us better prepared for future pandemic viruses."

Not all results were the same between the three studied viruses, however. Some human molecules required for SARS-CoV-2 infection weren't needed by the two common cold coronaviruses, and vice versa. These findings could help explain what makes SARS-CoV-2 more deadly than the other two viruses.

More work is needed to test the effectiveness of drugs targeting PIP and cholesterol, and whether they can effectively stop viral growth without causing dangerous side effects. The team would also like to repeat the screens using other coronaviruses--including the first SARS-CoV and MERS viruses--to determine just how universal the new targets they pinpointed are.

Ott and Puschnik agree that the current study was made possible by researchers from many labs coming together without hesitation. Puschnik has expertise in studying viral host factors, but didn't have access to a Biosafety Level 3 (BSL-3) lab required to work with SARS-CoV-2. Ott was spearheading Gladstone's effort to open such a lab earlier this year and offered to collaborate. Scientists at Synthego provided the engineered cells needed to study the viruses, and Gladstone Senior Investigator Nevan Krogan, PhD, helped analyze the results of the CRISPR-Cas9 screen.

"Everybody was completely willing to roll up their sleeves, pool resources, and work together to help contribute to better understanding COVID-19," says Puschnik.

Credit: 
Gladstone Institutes

Smartphone data shows real-time impact on health

ITHACA, N.Y. - Researchers at Cornell University are using smartphones to capture location and real-time survey data to examine how social environments encountered in everyday life may affect health.

Equipped with smartphones for a week, dozens of older New York City residents allowed a Cornell sociologist to track their movements and reported several times a day where they were, what they were doing and how they felt.

The 61 study participants, all age 55 or older, shared glimpses of their daily routines and activities: working at a bakery, being at home with a cat, walking in a park with grandchildren, visiting with friends, waiting in line for coffee and going to church. They also noted when they saw litter, vacant buildings, damaged sidewalks and other scenes they considered problematic, such as evidence of drug or alcohol use.

In the places they perceived as stressful or threatening, the older adults were significantly more likely to report momentary spikes in fatigue or pain, the study found. When observing at least two of those disorderly conditions, they were twice as likely to report feeling tired and about two-thirds more likely to report feeling pain.

"These fluctuations may have longer-term impacts on health and well-being for older adults who have to navigate demanding or distressing social environments on a regular basis," said Erin York Cornwell, lead author of the study.

In New York City, York Cornwell worked with community-based senior centers to recruit a diverse group of volunteers from four neighborhoods: East Harlem, Gramercy and the north and south sections of Bedford-Stuyvesant.

On average, about one-third of the study participants reported feeling some pain and about one-third some fatigue in any given survey, with those feelings being less prevalent in more orderly spaces. The risk increased with each additional condition of disorder observed.

The participants completed most of the surveys within 10 or 15 minutes of being pinged on their smartphones to complete one. Their overall response rate of nearly 99% is almost unheard of in survey research, York Cornwell said.

Researchers typically have relied on survey respondents to keep paper logs of their experiences, often recorded long after events occurred. Though still an emerging research method, York Cornwell said, smartphone-based data collection enables more immediate responses that promise to improve survey accuracy and reduce bias.

"It's an incredible tool for understanding how people experience and perceive their environments in real time, and then looking at how those environments may affect their health," she said. "We haven't been able to get that insight in such a clean way in the past, so this approach has really exciting implications."

Credit: 
Cornell University

Algorithms and automation: Making new technology faster and cheaper

image: Compared with traditional metal additive manufacturing, this process contains multiple printable volumes that started from different building surfaces with different orientations.

Image: 
Xinyi Xiao, Penn State

Additive manufacturing (AM) machinery has advanced over time, however, the necessary software for new machines often lags behind. To help mitigate this issue, Penn State researchers designed an automated process planning software to save money, time and design resources.

Newer, five-axis machines are designed to move linearly along an x, y and z plane and rotate between the planes to allow the machine to change an object's orientation. These machines are an advancement on the traditional three-axis machines that lack rotation capabilities and require support structures.

Such a machine can potentially lead to large cost and time savings; however, five-axis AM lacks the same design planning and automation that three-axis machines have. This is where the creation of planning software becomes critical.

"Five-axis AM is a young area, and the software isn't there yet," said Xinyi Xiao, a summer 2020 Penn State doctoral recipient in industrial engineering, now an assistant professor in mechanical and manufacturing engineering at Miami University in Ohio. "Essentially, we developed a methodology to automatically map designs from CAD -- computer-aided design -- software to AM to help cut unnecessary steps. You save money by taking less time to make the part and by also using less materials from three-axis support structures."

Xiao conducted this work as part of her doctoral program in the Penn State Harold and Inge Marcus Department of Industrial and Manufacturing Engineering under the supervision of Sanjay Joshi, professor of industrial engineering. Their research was published in the Journal of Additive Manufacturing.

"We want to automate the decision process for manufacturing designs to get to 'push button additive manufacturing,'" Joshi said. "The idea of the software is to make five-axis AM fully automated without the need for manual work or re-designs of a product. Xinyi came to me when she needed guidance or had questions, but ultimately, she held the key."

The software's algorithm automatically determines a part's sections and the sections' orientations. From this, the software designates when each section will be printed, and in which orientation within the printing sequence. Through a decomposition process, the part's geometry boils down into individual sections, each printable without support structures. As each piece is made in order, the machine can rotate throughout its axes to reorient the part and continue printing. Xiao compared it to working with Lego building blocks.

The algorithm can help inform a designer's process plan to manufacture a part. It allows designers opportunities to make corrections or alter the design before printing, which can positively affect cost. The algorithm can also inform a designer how feasible a part may be to create using support-free manufacturing.

"With an algorithm, you don't really need the expertise from the user because it's in the software," Joshi said. "Automation can help with trying out a bunch of different scenarios very quickly before you create anything on the machine."

Xiao said she intends to continue this research as some of the major application areas of this technology are aerospace and automobiles.

"Large metal components, using traditional additive manufacturing, can takes days and waste lots of materials by using support structures," Xiao said. "Additive manufacturing is very powerful, and it can make a lot of things due to its flexibility; however, it also has its disadvantages. There is still more work to do."

Credit: 
Penn State

Understanding COVID-19 infection and possible mutations

image: This schematic shows the difference in interactions between SARS-CoV and human ACE2 versus SARS-CoV-2 and human ACE2.

Image: 
Ratul Chowdhury, Penn State

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease. Penn State researchers computationally assessed how changes to the virus spike makeup can affect binding with ACE2 and compared results to those of the original SARS-CoV virus (SARS).

The researchers' original manuscript preprint, made available online in March, was among the first to computationally investigate SARS-CoV-2's high affinity, or tendency to bind, with human ACE2. The paper was published online on Sept. 18 in the Computational and Structural Biotechnology Journal. The work was conceived and led by Costas Maranas, Donald B. Broughton Professor in the Department of Chemical Engineering, and his former graduate student Ratul Chowdhury, who is currently a postdoctoral fellow at Harvard Medical School.

"We were interested in answering two important questions," said Veda Sheersh Boorla, doctoral student in chemical engineering and co-author on the paper. "We wanted to first discern key structural changes that give COVID-19 a higher affinity towards human ACE2 proteins when compared with SARS, and then assess its potential affinity to livestock or other animal ACE2 proteins."

The researchers computationally modeled the attachment of SARS-CoV-2 protein spike to ACE2, which is located in the upper respiratory tract and serves as the entry point for other coronaviruses, including SARS. The team used a molecular modeling approach to compute the binding strength and interactions of the viral protein's attachment to ACE2.

The team found that the SARS-CoV-2 spike protein is highly optimized to bind with human ACE2. Simulations of viral attachment to homologous ACE2 proteins of bats, cattle, chickens, horses, felines and canines showed the highest affinity for bats and human ACE2, with lower values of affinity for cats, horses, dogs, cattle and chickens, according to Chowdhury.

"Beyond explaining the molecular mechanism of binding with ACE2, we also explored changes in the virus spike that could change its affinity with human ACE2," said Chowdhury, who earned his doctorate in chemical engineering at Penn State in fall 2019.

Understanding the binding behavior of the virus spike with ACE2 and the virus tolerance of these structural spike changes could inform future research on vaccine durability and the potential for the virus to spread to other species.

"The computational workflow that we have established should be able to handle other receptor binding-mediated entry mechanisms for other viruses that may arise in the future," Chowdhury said.

Credit: 
Penn State

New treatment in development for irritable bowel syndrome with constipation

Patients suffering from irritable bowel syndrome with constipation (IBS-C) have long needed an upgrade in treatment. Rapid-release, cramp-inducing doses of chenodeoxycholic acid (CDC) have previously shown promise in treating constipation, but further development has been hampered by the abdominal pain associated with the sudden release of CDC. Researchers at Brigham and Women's Hospital and the Massachusetts Institute of Technology (MIT) devised a plan to deliver CDC in a bilayered capsule, finding that this mode of delivery could decrease colon cramping and thus produce a better patient experience. In preclinical studies, the team found evidence that this bilayered delivery system has the potential to reduce cramping and provide constipation relief. Findings are published in Clinical and Translational Gastroenterology.

"We know bile acids are capable of helping with motility, but what has been attempted in the past is giving a bolus -- a boatload of bile acid all at once. This manifests in increased bowel movements, but also pain," said Giovanni Traverso, MD, PhD, of the Brigham's Division of Gastroenterology, Hepatology and Endoscopy and the Department of Mechanical Engineering at MIT. "Could we take this endogenous, natural product and deliver it in a way that overcomes this risk of contractions?"

The liver produces bile acids to aid in the digestive process, regulating intestinal motility, fluid homeostasis, and humoral activity. Bile acids, such as pro-motility CDC, have been previously studied in patients for their pro-motility effects and recognized to enhance water ingression and bowel motility. The challenge has been how to administer these in ways that minimize potential side effects; to accomplish this, researchers developed a bilayered delivery system.

The bilayered delivery mechanism was tested in swine models for half-life, colon cramping and whether it caused a similar dosage spike to single-layered delivery. Immediate release of the pill's surface layer established a healthy local concentration of CDC, which in turn offered enough colonic fluid to initiate the pill's second, slower-release layer of CDC. This biphasic release of CDC established a low-dose, long-lasting presence of bile acid over time, avoiding the dosage spike and decreasing cramping.

Several important limitations exist for this study, including lack of similar studies for comparison and shortcomings of the swine model; the team was not able to measure levels of abdominal pain in the swine model, and only rectal contractions were measured, as opposed to a full colonic evaluation.

Within the next 18 months, clinical trials will begin for the bilayered delivery of CDC to IBS-C patients, with pill production regulated by the team's newly founded Bilayer Therapeutics. Traverso envisions applications for this therapeutic far beyond IBS-C. Bile acids are involved in metabolic diseases, including diabetes and liver cytopathy.

"While further studies are necessary to demonstrate the therapeutic potential of these systems in humans, our findings suggest that controlled delivery of bile acids to the colon may represent a novel approach to treating gastrointestinal diseases such as constipation," said co-author Joshua Korzenik, MD, of the Brigham's Gastroenterology and Hepatology Division.

Credit: 
Brigham and Women's Hospital

Colorado mountains bouncing back from 'acid rain' impacts

image: Meadows, forests and mountain ridges create the high alpine landscapes of Niwot Ridge in the Rocky Mountains, 25 miles northwest of Boulder, Colorado.

Image: 
William Bowman

A long-term trend of ecological improvement is appearing in the mountains west of Boulder. Researchers from the University of Colorado Boulder have found that Niwot Ridge--a high alpine area of the Rocky Mountains, east of the Continental Divide--is slowly recovering from increased acidity caused by vehicle emissions in Colorado's Front Range.

Their results show that nitric and sulfuric acid levels in the Green Lakes Valley region of Niwot Ridge have generally decreased over the past 30 years, especially since the mid-2000s. The findings, which suggest that alpine regions across the Mountain West may be recovering, are published in the Journal of Geophysical Research: Biogeosciences.

This is good news for the wildlife and wildflowers of Rocky Mountain National Park to the north of Niwot Ridge, which depend on limited levels of acidity in the water and soil to thrive. Colorado's Rocky Mountains are also the source of a lot of water for people living in the Mountain West, and the integrity of these ecosystems influences both the quantity and the quality of this water.

"It looks like we're doing the right thing. By controlling vehicle emissions, some of these really special places that make Colorado unique are going back to what they used to be," said Jason Neff, co-author on the paper and director of the Sustainability Innovation Lab at Colorado (SILC).

Almost every area in the world, including Colorado's Rocky Mountains, has been affected in the past 200 years by increased acidic nutrients, like nitrogen, contained in rain and snow. Nitrogen oxides, like nitrate, are produced primarily from vehicles and energy production. Ammonium is a main ingredient in common agricultural fertilizers.

Nitrogen is a fundamental nutrient required in ecosystems. But when nitrogen levels increase too much, this changed soil and water chemistry can make it difficult for native plants to thrive or even survive--leading to a cascade of negative consequences.

In the summer, the sun heats up the Eastern flanks of the Front Range, causing the warmer air to rise--bringing nitrogen from cars, industry and agriculture with it. As this air cools, it forms clouds over the Rocky Mountains and falls back down as afternoon thunderstorms--depositing contaminants, explained Neff.

In the 1970s, so-called "acid rain" hit East Coast ecosystems much harder than the Mountain West, famously wiping out fish populations and killing trees across large swaths of upstate New York. But scientists are still working to understand how increased levels of acidic nutrients affect the alpine region and how long these ecosystems take to recover.

To fill this gap of knowledge, the researchers analyzed data from 1984 to 2017 on atmospheric deposition and stream water chemistry from the Mountain Research Station, a research facility of the Institute of Arctic and Alpine Research (INSTAAR) and CU Boulder located on Niwot Ridge. They found that around the early 2000s, levels of nitric and sulfuric acid stopped increasing in the Green Lakes Valley. In the mid-2000s they started decreasing.

Their findings were not all good news, however. Levels of ammonium from fertilizer have more than doubled in rainfall in this area between 1984 and 2017, indicating a need to continue monitoring this agricultural chemical and its effects on the mountain ecosystem.

From field work to statistics

This work builds on decades of field work by Colorado researchers at CU Boulder and beyond.

Niwot Ridge is one of 28 Long Term Ecological Research (LTER) Network sites in the U.S., funded by the National Science Foundation. Its 4 square miles stretch from the Continental Divide down to the subalpine forest, 25 miles northwest of Boulder. Researchers at CU Boulder, as well as Colorado State University and the United States Geological Survey, have been collecting data here since the mid-1970s, hiking through snow, sleet and rain to get it.

In the 80s, 90s and 2000s they worked to bring attention to increasing acidification in Colorado mountain ecosystems as a need for pollution regulation in the Front Range.

This new research was made possible by these dedicated scientists, stresses Neff.

"We used water quality modeling and statistical approaches to analyze the long-term datasets that Niwot researchers have been collecting for decades," said Eve-Lyn Hinckley, a co-author on the paper and fellow of INSTAAR. "The data are available for anyone to download. Our modeling approaches allowed us to evaluate the patterns they hold in a rigorous way."

Since 1990, Bill Bowman, director of the Mountain Research Station and a professor of ecology and evolutionary biology, has been looking into how nutrients like nitrogen affect plants in mountain ecosystems. He's found that alpine environments are unique in how they respond to these nutrients.

"It's a system that is adapted to low nutrients, as well as a harsh climate and a very short growing season--and frost in the middle of the season. These are very slow growing plants. And they just simply can't respond to the addition of more nitrogen into the system," said Bowman, also a fellow in INSTAAR.

He has also found that these ecosystems recover quite slowly, even after acidic elements like nitrogen are no longer being added. But like Neff, who completed his undergraduate honors thesis with Bowman in 1993 using Niwot Ridge data, he sees this research as encouraging.

Even if it's slow going, they said, these results show that the ecosystem has a chance to recover.

"We still have air quality issues in the Front Range. But even with those air quality issues, this research shows that regulating vehicle and power plant emissions is having a big impact," said Neff.

Credit: 
University of Colorado at Boulder

'SCOUT' helps researchers find, quantify significant differences among organoids

video: The ability to culture cerebral organoids or "minibrains" using stem cells derived from people has given scientists experimentally manipulable models of human neurological development and disease, but not without confounding challenges. No two organoids are alike and none of them resemble actual brains. This "snowflake" problem has held back the science by making scientifically meaningful quantitative comparisons difficult to achieve. To help researchers overcome those limitations, MIT neuroscientists and engineers have developed SCOUT, a new pipeline for clearing, labeling, 3D imaging and rigorously analyzing organoids.

Image: 
MIT Picower Institute

The ability to culture cerebral organoids or "minibrains" using stem cells derived from people has given scientists experimentally manipulable models of human neurological development and disease, but not without confounding challenges. No two organoids are alike and none of them resemble actual brains. This "snowflake" problem has held back the science by making scientifically meaningful quantitative comparisons difficult to achieve. To help researchers overcome those limitations, MIT neuroscientists and engineers have developed a new pipeline for clearing, labeling, 3D imaging and rigorously analyzing organoids.

Called "SCOUT" for "Single-Cell and Cytoarchitecture analysis of Organoids using Unbiased Techniques," the process can extract comparable features among whole organoids despite their uniqueness - a capability the researchers demonstrate via three case studies in their new paper in Scientific Reports. In one of the case studies, for example, the team reports new patterns of disruption in organoid development from Zika virus infection, providing new insights into why babies born to infected mothers can exhibit severe neurological deficits.

"When you are dealing with natural tissues you can always subdivide them using a standard tissue atlas, so it is easy to compare apples to apples," said study co-lead author Alexandre Albanese, a research scientist in the lab of the paper's senior author, Associate Professor Kwanghun Chung. "But when every organoid is a snowflake and has its own unique combination of features, how do you know when the variability you observe is because of model itself rather than the biological question you are trying to answer? We were interested in cutting through the noise of the system to make quantitative comparisons."

Albanese co-led the research with former MIT chemical engineering graduate student Justin Swaney. The team has taken the added step of sharing their software and protocols on GitHub so that it can be freely adopted. Chung said that by sharing many of his lab's tissue processing, labeling and analysis innovations, he hopes to speed up biomedical progress.

"We are developing all these technologies to enable more holistic understanding of complex biological systems, which is essential to accelerate the pace of discovery and the development of therapeutic strategies," said Chung, an investigator in The Picower Institute for Learning and Memory and the Institute for Medical Engineering and Science as well as a faculty member in Chemical Engineering and Brain and Cognitive Sciences. "Disseminating these technologies is as important as developing them to make a real-world impact."

Abstracting architecture

Several of the Chung lab's technologies are components of the SCOUT pipeline. The process starts by making organoids optically transparent so they can be imaged with their 3D structure intact--a key capability, Chung said, for studying whole organoids as developing systems. The next SCOUT step is to infuse the cleared organoids with antibody labels targeting specific proteins to highlight cellular identity and activity. With organoids cleared and labeled, Chung's team images them with a light-sheet microscope to gather a full picture of the whole organoid at single-cell resolution. In total, each organoid produces about 150 GB of data for automated analysis by SCOUT's software, principally coded by Swaney.

The high-throughput process allows for many organoids to be processed, ensuring that research teams can include many specimens in their experiments.

The team chose its antibody labels strategically, Albanese said. With a goal of discerning cell patterns arising during organoid development, the team decided to label proteins specific to early neurons (TBR1) and radial glial progenitor cells (SOX2) because their organization impacts downstream development of the cortex. The team imbued SCOUT with algorithms to accurately identify every distinct cell within each organoid.

From there, SCOUT could start to recognize common architectural patterns such as identifying locations where similar cells cluster or areas of greater diversity, as well as how close or far different cell populations were from ventricles, or hollow spaces. In developing brains and organoids alike, cells organize around ventricles and then migrate out radially. With the aid of artificial intelligence-based methods, SCOUT was able to track patterns of different cell populations outward from each ventricle. Working with the system, the team therefore could identify similarities and differences in the cell configurations, or cytoarchitectures, across each organoid.

Ultimately the researchers were able to build a set of nearly 300 features on which organoids could be compared, ranging from the single-cell to whole-tissue level. Chung said that with further analysis and different molecular label choices even more features could be developed. Notably, the features extracted by SCOUT are unbiased, because they are products of the software's analysis, rather than pre-ordained hypotheses about what is "supposed to be" meaningful.

Scientific comparisons

With the analytical pipeline set, the team put it to the test. In one case study they used it to discern trends of organoid development by comparing specimens of different ages. SCOUT highlighted dozens of significant differences not only in overall growth, but also changes in the proportions of cell types, differences in layering, and other changes in tissue architecture consistent with maturation.

In another case study they compared different methods of culturing organoids. Harvard University co-authors Paola Arlotta and Silvia Velasco have developed a method that, according to single-cell RNA sequencing analysis, produces more consistent organoids than other protocols. The team used SCOUT to compare them with conventionally produced organoids to assess their consistency at the tissue scale. They found that the "Velasco" organoids show improved consistency in their architectures, but still show some variance.

Zika insights

The third case study involving Zika not only proved the utility of SCOUT in detecting major changes, but also led to the discovery of rare events. Chung's group collaborated with virus expert Lee Gehrke, Hermann L.F. von Helmholtz Professor in IMES, to determine how Zika infection changed organoid development. SCOUT spotted 22 major differences between infected and uninfected organoids, including some that had not been documented before.

"Overall this analysis provided a first-of-its kind comprehensive quantification of Zika-mediated pathology including loss of cells, reduction of ventricles and overall tissue reorganization," the authors wrote. "We were able to characterize the spatial context of rare cells and distinguish group-specific differences in cytoarchitectures. Infection phenotype reduced organoid size, ventricle growth and the expansion of SOX2 and TBR1 cells. Given our observation that SOX2 cell counts correlate with multiscale tissue features, it is expected that Zika-related loss of neural progenitors decreased in the complexity of tissue topography and cell patterning."

Chung said his lab is also collaborating with colleagues studying autism-like disorders to learn more about how development may differ.

Credit: 
Picower Institute at MIT

Risk of serious complications during knee replacement 73% higher when a tourniquet is used

New research from University of Warwick shows that knee replacement surgery using a tourniquet increases the risk of serious complications, and causes additional pain after surgery

A tourniquet is a device which is wrapped tightly around the thigh to stop blood flow to the rest of the leg

Researchers calculate that a change in knee replacement surgical practice might avoid nearly 2,000 serious complications a year in the UK alone

The research shows that when a tourniquet is used patients have on average nearly 20% more pain the day after the surgery

Use of a tourniquet is established practice amongst the majority of knee surgeons, however, a minority perform the surgery without a tourniquet

The risk of developing serious complications following a knee replacement could be up to 73% higher when a tourniquet is used, compared to surgery without a tourniquet.

Serious complications during knee replacement surgery are rare. However, researchers at the University of Warwick found that 5.9% of patients whose operations involved a tourniquet had serious complications needing additional health care, compared to 2.9% in those operated on without a tourniquet.

Research from Warwick Clinical Trials Unit has revealed that this common surgery, performed over 100,000 times a year in the UK, is likely to be safer and less painful for patients if surgeons do not use a tourniquet. A tourniquet is a device which is wrapped around the thigh and squeezes it to stop blood flow to the rest of the leg. It is typically applied for about an hour during the surgery.

The conclusions are drawn from a new systematic review publishing today (8 December) in the Cochrane Library and funded by the National Institute for Health Research, drawing on data from 41 previous clinical trials on the use of a tourniquet during knee replacement surgery. The differences became clear when the results from multiple studies around the world were combined.

The researchers conclude that surgeons should now discuss the benefits and risks of using a tourniquet with patients prior to surgery and offer a choice of whether to use a tourniquet or not. The report suggests that a change of surgical practice by not using a tourniquet might avoid up to 1,987 serious complications in the UK each year.

Many people with arthritis are successfully treated with painkillers, exercise and physiotherapy. When arthritis becomes severe, these may be less effective and patients are typically offered knee replacement surgery. This procedure is performed under anaesthetic when the knee joint is opened up, the worn joint surfaces are removed and replaced with artificial surfaces usually constructed from metal and plastic.

Widespread use of tourniquets may relate to surgeons' concerns about blood loss and improving the way that the cement used to hold the knee replacement in place attaches to the bone. However, modern anaesthetic and surgical techniques mean this is unlikely to be a problem. For example, hip and shoulder replacement surgery where the use of a tourniquet is not possible proceed safely, without undue concerns about bleeding or cement fixation of the components. The researchers found no evidence of any problem with the attachment between the cement and the bone when a tourniquet was not used, even in x-ray studies designed to measure this accurately.

The researchers pooled data from 41 previous randomised control trials up to March 2020, involving 2,819 patients, comparing the outcomes when the surgeon used a tourniquet during knee replacement surgery to those who didn't use a tourniquet. Knee function, quality of life, total blood loss and fixation of the components were measured and little difference was found between the two methods. However, where a tourniquet was used 5.9% of patients experienced serious complications such as blood clots, wound infection and the need for further surgery, compared to 2.9% where a tourniquet was not used. Patients who had a knee replacement where a tourniquet was used also reported on average 19% more pain the day after surgery than patients where no tourniquet was used.

Senior author Mr Peter Wall, Consultant Orthopaedic Surgeon from Warwick Clinical Trials Unit and University Hospitals Coventry and Warwickshire NHS Trust, said: "The evidence indicates that knee replacement surgery performed with a tourniquet increases the risk of serious complications needing additional healthcare, many of which might be avoided if a tourniquet is not used.

He emphasised that: "Most people do very well after knee replacement, but like any major surgery, there are risks and use of a tourniquet may exacerbate these."

Credit: 
University of Warwick

Magnetic bacteria as micropumps

Cancer drugs have side effects, so for many years, scientists have been exploring ways to transport the active substances to a tumour in the body as precisely as possible. That is the only place that drugs should take effect. One approach is to inject them into the bloodstream and control their transport in small vessels at tumour sites by locally altering the blood flow with tiny vehicles. Research laboratories have created microrobots whose shape and propulsion are inspired by bacteria and that are small enough to be inserted into blood vessels.

These microvehicles can be powered from outside the body by a moving magnetic field.

Simone Schürle, Professor at the Department of Health Sciences and Technology, is now going one step further: instead of microrobots inspired by bacteria, she wants to use real bacteria that are magnetic. Researchers discovered such magnetotactic bacteria in the sea 45 years ago. These microorganisms absorb iron dissolved in the water; iron oxide crystals form in their interior and line up in a row. Like a compass needle, these bacteria align themselves with the Earth's magnetic field so they can navigate in the water in a directed manner.

Precise control with magnetic fields

ETH Professor Schürle and her team investigated how to use a magnetic field to control these bacteria in the laboratory as a way to direct the flow of liquids in a controlled manner. In their experiments, they applied only relatively weak rotating magnetic fields to spin the bacteria along the desired directions. And with many bacteria in a swarm, it proved possible to move the fluid surrounding them. The bacteria produce an effect similar to that of a micropump, meaning they are able to move active substances present in the fluid in different directions, for example from the bloodstream into the tumour tissue. By using superimposed magnetic fields that locally reinforce or cancel each other out, this pumping activity can be confined to a small region with pinpoint accuracy, as Schürle's team has been able to show in simulations.

Moreover, the principle can be put to work outside the body to mix different liquids locally with each other in very small vessels without having to manufacture and control mechanical micropumps.

"One major advantage of bacteria over microrobots is that they are easy to produce. We can simply cultivate them in bioreactors," Schürle says.

Dead or alive

Their work is primarily focused on investigating the approach and describing how the bacteria can control the flow. Before such bacteria can be used in the human body, their safety must first be investigated. However, bringing bacteria into the body for medical reasons is an approach that science is already pursuing under the term "living therapeutics", albeit with other types of bacteria, such as E. coli.

It should also be possible to use non-natural bacteria for future medical applications. Synthetic biology can be used to construct bacteria that feature optimised functional properties and are safe for use in the human body, for example by not causing allergic reactions. Schürle can envisage treatments using bacteria that are killed before they are introduced into the body as well as treatments using living bacteria.

Fine control through self-propulsion

It has also been known for several decades that certain types of anaerobic bacteria (which do not require oxygen to grow) preferably accumulate in cancer patients' tumours. In other words, these bacteria naturally prefer the low oxygen conditions in tumours over the rest of the body. While this was investigated in bacteria other than those used by Schürle's team, synthetic biology could be used to combine the advantages of several bacterial species. This might lead to the development of bacteria that approach the tumour powered by their own flagella (whip-like appendages) and can then be precisely transported deep into the tumour tissue using external magnetic forces.

Credit: 
ETH Zurich

Study confirms dark coating can reduce satellite reflectivity

image: The trail of a Starlink satellite (the line from upper right to lower left) captured by the Murikabushi Telescope on April 10, 2020.

Image: 
NAOJ

Observations conducted by the Murikabushi Telescope of Ishigakijima Astronomical Observatory confirmed that dark coating can reduce satellite reflectivity by half. There are concerns that numerous artificial satellites in orbit could impair astronomical observations, but these findings may help alleviate such conditions.

Today's growing demand for space-based services has spawned a wave of satellite constellation projects which operate numerous artificial satellites in orbit. Since these satellites can shine by reflecting sunlight, the astronomy community has raised concerns about their potential impact on astronomical observations. In January 2020, SpaceX launched "DarkSat," an experimental satellite with an anti-reflective coating, and asked astronomers to assess how much this coating can reduce the satellite reflectivity. Brightness measurements of artificial satellites have already been conducted, but until now, there was no verification that a dark coating actually achieves the expected reflectivity reduction.

The Murikabushi Telescope of Ishigakijima Astronomical Observatory can observe celestial objects simultaneously in three different wavelengths (colors). Comparing multicolor data obtained under the same conditions provides more accurate insight into how much the coating can reduce the satellite brightness. Observations conducted from April to June 2020 revealed for the first time in the world that artificial satellites, whether coated or not, are more visible at longer wavelengths, and that the black coating can halve the level of surface reflectivity of satellites. Such surface treatment is expected to reduce the negative impacts on astronomical observations. Further measures will continue to be implemented to pave the way for peaceful coexistence between space industries and astronomy.

Credit: 
National Institutes of Natural Sciences

New findings shed light on the repair of UV-induced DNA damage

image: The white arrows indicate the molecules with attached fluorescent proteins that have accumulated at UV-induced DNA damage sites.

Image: 
Kobe University

An international research team has clarified the regulatory mechanism of the ubiquitin-proteasome system (*1) in recognizing and repairing DNA that has been damaged by ultraviolet (UV) light. The investigators at Kobe University (Japan), the National Institute of Health Sciences (Japan), the Catholic University of Louvain (Belgium), Kyoto University (Japan), and the National Institute of Genetics (Japan) have published their results in the journal Scientific Reports.

Main Points

The researchers developed a microscope system whereby they could induce DNA damage to any intracellular location via UV light stimulation and observe cellular responses in real time.

They observed that proteasome, which is a multi-protein complex involved in protein degradation, quickly accumulated at the sites of the UV light-induced DNA damage.

This research has illuminated that the enzymatic activity and structural integrity of the proteasome are vital for the DNA damage recognition pathway, which is mediated by DDB2 proteins. Mutation in the DDB2 gene occurs in the genetic disorder xeroderma pigmentosum (*2).

Research Background

UV light from the sun is very harmful to living organisms because it can damage their genes. This is called DNA damage and normally it is fixed by the repair system in our cells, preventing us from experiencing adverse effects resulting from exposure to sunlight during the course of our daily lives. However, patients with xeroderma pigmentosum (XP) are born with malformations in this repair system, which means that their bodies are unable to sufficiently repair DNA damage caused by UV light. Consequently, they are predisposed to developing skin cancer in sun-exposed areas.

Intracellular proteins are generated and degraded as required, and the ubiquitin-proteasome system is known to play an important role in managing this degradation process. It has been previously shown that the ubiquitin-proteasome system coordinates cellular responses to repair the UV-induced DNA damage. However, the detailed mechanism behind this had not been clarified until now.

Research Findings

The international team, led by Prof. SUGASAWA Kaoru at the Biosignal Research Center, Kobe University, developed a custom microscope system (*3) which allowed them to successfully observe the dynamic behaviors of various intracellular proteins in response to UV-induced DNA damage (Figure 1, left).

The DDB2 protein is one of the gene products responsible for XP and is important for recognizing UV-induced DNA damage. Utilizing the custom microscope system enabled the researchers to make a new discovery: they found that the DDB2 protein works together with the ubiquitin-proteasome system to promote DNA repair. First of all, the multi-protein complexes, proteasomes, quickly accumulated at DNA damage sites depending on the presence of DDB2 proteins. This suggests that the proteasome's protein degradation function could be activated following the damage recognition and repair (Figure 1, right).

Furthermore, using an inhibitor to suppress this proteasome activity caused the proteasome to accumulate in a specific region of the nucleus, trapping the DDB2 protein and making it unable to participate in DNA damage repair (Figure 2). On the other hand, suppressing the expression of proteasome subunits compromised proper assembly of the proteasomes and the aforementioned proteasome aggregation was no longer observable. However, the absence of proteasomes severely suppressed the accumulation of DDB2 proteins at DNA damage sites.

These results revealed for the first time that proteasomes' protein degradation activity and architectural integrity are involved in the regulation of DDB2 protein-mediated DNA damage repair via separate mechanisms.

Further Developments

The results of this study show that the action of the DNA damage recognition mechanism is essential for enabling DNA damage to be efficiently repaired. Furthermore, this understanding will also contribute towards clarifying the onset mechanisms of diseases such as skin cancer, in addition to the development of treatments to suppress this onset.

Credit: 
Kobe University

The world's smallest high-performance magnetic tunnel junction

image: Schematic illustrations of the shape-anisotropy MTJ (a) with the conventional single ferromagnetic structure (developed in 2018) and the multilayered ferromagnetic structure (b) using magnetostatic coupling. In the multilayered ferromagnetic structure, device performance can be improved by enhancing the interfacial anisotropy, and the two ferromagnets behave as a single magnet owing to magnetostatic coupling. This enables the ferromagnetic layer to become thinner while maintaining high thermal stability.

Image: 
Butsurin Jinnai and Shunsuke Fukami

A research group from Tohoku University led by current president Hideo Ohno has developed the world's smallest (2.3 nm) high-performance magnetic tunnel junctions (MTJs). This work is expected to accelerate the advancement of ultrahigh-density, low-power, high-performance non-volatile memory for a variety of applications, such as IoT, AI, and automobiles.

The development of STT-MRAM--non-volatile spintronics memory--helps reduce the increasing power consumption in semiconductor device scaling. Crucial to integrating STT-MRAM in advanced integrated circuits is scaling magnetic tunnel junction--a core component of STT-MRAM--while improving its performance in data retention and write operation.

Shape-anisotropy MTJ, proposed by the same group in 2018, has shown MTJ scaling down to single-digit nanometers while achieving sufficient data-retention (thermal-stability) properties. In the shape-anisotropy MTJ, thermal stability is enhanced by making the ferromagnetic layer thick. Once the thickness goes beyond a certain point, however, device reliability becomes degraded.

To address the issue in the conventional shape-anisotropy MTJ with a single ferromagnetic structure [Fig. 1(a)], the group employed a new structure that uses magnetostatically coupled multilayered ferromagnets [Fig. 1(b)]. The developed MTJs were successfully scaled down to 2.3 nm in diameter -the world's smallest MTJ size. They also exhibited high data retention properties up to 200°C and high-speed and low-voltage write operation down to 10 ns below 1 V at a single-digit-nanometer scale.

"The performance proves the developed MTJs' capability to work with the future-generation advanced integrated circuits," said Butsurin Jinnai, first author of the study. "Because of its material compatibility with the standard MTJ material system, CoFeB/MgO, the proposed MTJ structure can be easily adopted in existing MTJ technology." The group believes that this will speed up the development of ultrahigh-density, low-power, high-performance memory for a variety of applications, such as IoT, AI, and automobiles.

Credit: 
Tohoku University

The gut microbiome in polycystic ovary syndrome and its association with metabolic traits

University of Tartu researchers and their collaborators from Finland and Spain investigated the relationship between the gut microbiome and polycystic ovary syndrome. Their study revealed that women with polycystic ovary syndrome in their late reproductive years have significant microbial changes in gut-related to their metabolic health.

Polycystic ovary syndrome is a complex hormonal disorder affecting up to 18% of women in reproductive age. Women with polycystic ovary syndrome often have irregularities in their menstrual cycle, excess of male sex hormones and polycystic ovarian morphology. It is associated with a variety of metabolic derangements, including obesity, insulin resistance and type 2 diabetes. The exact cause of polycystic ovary syndrome is unknown but it is believed to be multifactorial where genetics, lifestyle and possibly the gut microbiome could have a role.

This study aimed to assess whether the gut microbiome is associated with polycystic ovary syndrome in late fertile age women. "Our study population consisted of a subset of females from the longitudinal Northern Finland Birth Cohort 1966, which includes all expected births in 1966 in the two northernmost provinces of Finland," said the first author of the paper Kreete Lüll.

Results show that there are no significant differences in gut microbiome between women who have polycystic ovary syndrome and healthy women in their late fertile age. "Yet, we found differences between the microbial diversity and hormones," said Lüll. Furthermore, the results show that there are differences in microbiome profile in women with polycystic ovary syndrome in a pre-diabetic state compared to those with normal glucose tolerance.

"Although this study shed some light on the causes of polycystic ovary syndrome, further research with a larger sample set among younger women is needed in order to clarify the possible link between the gut microbiome, metabolites and development of polycystic ovary syndrome," added the last author, Senior Research Fellow of Molecular Biomedicine Elin Org.

Credit: 
Estonian Research Council

Transforming the scientific community

The members of ACNP have been motivated by recent events to strengthen diversity and inclusivity programs within the College and find ways to promote change in our home institutions. Two Annual Meeting Study Groups provided both information and practical action steps for members. The first addressed the challenge of moving beyond diversity and inclusivity as "buzzwords" toward institutional change. Evidence-based strategies were discussed that can be used widely at academic institutions, in medical and scientific education specifically, within ACNP and at members' home institutions. The second Study Group addressed microaggressions, brief daily encounters that convey negative messages to members within specific biographical groups. While overt racism, sexism and classism in professional settings has decreased due to clear policies developed by institutions and professional organizations, microaggressions remain across all levels of scientific training and academic rank and contribute to the low representation of women and underrepresented minority groups among academic leadership. Women make up only 18% of medical school deans, while those from underrepresented minority groups account for 12% of deans. The Study Group provided insight into how and why microaggressions occur and discussed practical strategies to raise awareness and provided easy to remember and implementable strategies to eliminate them.

Inclusion and Diversity Efforts Within Large Scientific Organizations: Tangible Methods that Work

There is no clear consensus on how to enhance diversity and inclusivity at institutions, and these efforts are often assigned to members of underrepresented groups who are most affected and lack the authority and resources to effect institutional change. This study group co-Chaired by Dr. April Thames of the University of Southern California and Dr. Sade Spencer of the University of Minnesota addressed evidence-based methods to effect transformation in scientific institutions like the American College of Neuropsychopharmacology. Dr. April Thames discussed strategies including translating workgroup efforts into tangible outcomes and products, using social media and collaborating with colleagues and leadership. Dr. Erika Nurmi of UCLA illustrated challenges and successes at promoting diversity and inclusion in medical and scientific education at UCLA to provide examples to apply to ACNP and to members' place of work. Dr. Shawn McClintock showed how to infuse inclusion and diversity into the ACNP meeting programs. Finally, Dr. Sade Spencer led an interactive discussion with the audience. This study group set the stage for implementing and sustaining diversity and inclusions practices at ACNP and its members' institutions.

The Mega Impact of Microaggression: Insights and Practical Solutions

The Study Group co-Chaired by Dr. Gretchen Neigh of Virginia Commonwealth University and Dr. Maria Oquendo of University of Pennsylvania discussed difficulties raised by microaggressions, how implicit bias can further perpetuate the cycle and outlined ways that bystanders and victims can break the cycle. Examples of common microaggressions were discussed including those related to gender (i.e. assumptions that absent female faculty members are home with children as opposed to traveling or attending conferences), race and/or culture (i.e. asking a colleague from an underrepresented group where they are 'really from'), and heteronormative behaviors (i.e. refusing to use preferred pronouns). Dr. VJ Periyakoi from Stanford University discussed ways microaggressions occur in academic settings. Dr. Catherine Njathi-Ori of the Mayo Clinic provided specific actions that individuals can use to address microaggression as they occur. Dr. Christine Moutier of the American Foundation for Suicide Prevention outlined communication strategies to change culture. Discussion after the presentations provided scenarios to help participants recognize microaggressions, appreciate their cost, and respond productively.

Credit: 
American College of Neuropsychopharmacology